Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
Yaowaluck Hongkaew,1,2 Nattawat Ngamsamut,3 Apichaya Puangpetch,1,2 Natchaya Vanwong,1,2 Pornpen Srisawasdi,4 Montri Chamnanphon,1,2 Bhunnada Chamkrachchangpada,3 Teerarat Tan-kam,3 Penkhae Limsila,3 Chonlaphat Sukasem1,2 1Division of Pharmacogenomics and Personalized Medicine, Department...
Guardado en:
Autores principales: | Hongkaew Y, Ngamsamut N, Puangpetch A, Vanwong N, Srisawasdi P, Chamnanphon M, Chamkrachchangpada B, Tan-kam T, Limsila P, Sukasem C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a13191af583040abb2d95260cbc95ae1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder
por: Medhasi S, et al.
Publicado: (2016) -
Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone
por: Yaowaluck Hongkaew, et al.
Publicado: (2021) -
Risperidone for children and adolescents with autism spectrum disorder: a systematic review
por: Maneeton N, et al.
Publicado: (2018) -
Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar F, et al.
Publicado: (2015) -
Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
por: Roberto Canitano, et al.
Publicado: (2008)